Literature DB >> 18313609

Suppression of atrial fibrillation with mexiletine pharmacotherapy in a young woman with type 1 long QT syndrome.

Malek El Yaman1, James Perry, Jonathan C Makielski, Michael J Ackerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18313609     DOI： 10.1016/j.hrthm.2007.10.029

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN： 1547-5271            Impact factor:   6.343


× No keyword cloud information.
  6 in total

1.  Action potential shortening rescues atrial calcium alternans.

Authors:  Giedrius Kanaporis; Zane M Kalik; Lothar A Blatter
Journal:  J Physiol       Date:  2018-12-05       Impact factor: 5.182

2.  Prevalence of early-onset atrial fibrillation in congenital long QT syndrome.

Authors:  Jonathan N Johnson; David J Tester; James Perry; Benjamin A Salisbury; Carol R Reed; Michael J Ackerman
Journal:  Heart Rhythm       Date:  2008-02-08       Impact factor: 6.343

Review 3.  Clinical use of and future perspectives on antiarrhythmic drugs.

Authors:  Juan Carlos Estrada; Dawood Darbar
Journal:  Eur J Clin Pharmacol       Date:  2008-09-02       Impact factor: 2.953

4.  Mouse Models of SCN5A-Related Cardiac Arrhythmias.

Authors:  Mickael Derangeon; Jérôme Montnach; Isabelle Baró; Flavien Charpentier
Journal:  Front Physiol       Date:  2012-06-22       Impact factor: 4.566

Review 5.  Atrial arrhythmias in inherited arrhythmogenic disorders.

Authors:  Can Hasdemir
Journal:  J Arrhythm       Date:  2016-02-09

6.  Atrial fibrillation in cardiac channelopathies.

Authors:  Jayachandran Thejus; Johnson Francis
Journal:  Indian Pacing Electrophysiol J       Date:  2009-11-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.